Medscape Medical News > Psychiatry Deborah Brauser August 19, 2014 (Updated Aug. 20, 2014) Atypical antipsychotic medications are linked to acute kidney injury (AKI) in elderly patients, new research suggests, causing investigators to call for their use in this population to be reevaluated. A population-based study examining medical records for nearly 200,000 adults older than […]
PracticeUpdate RESEARCH · July 09, 2014 TAKE-HOME MESSAGE This study used data from the National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance system to estimate the number of adverse drug events (ADEs) involving psychiatric medications among US adults resulting in emergency department (ED) visits. Annually from 2009 to 2011, there were nearly 90,000 ED […]
Nancy A. Melville August 21, 2013 Full Story: http://www.medscape.com/viewarticle/809720 The US Department of Health and Human Services’ Office of Inspector General (OIG) has launched a probe into the prescribing of atypical antipsychotic medications to children under Medicaid. “We will determine the extent to which children ages 18 and younger had Medicaid claims for atypical antipsychotic […]
Anti-psychotic medications should not be the first treatments doctors or patients think of when dealing with dementia in an elderly person, behavior problems in a child or insomnia in an adult, a leading group of psychiatrists says in a new statement.
Mark Crane May 10, 2013 The acid blocker esomeprazole (Nexium, AstraZeneca) and the antipsychotic medication aripiprazole (Abilify, Otsuka Pharmaceutical Co) are the top-selling US prescription drugs for the first quarter of this year, according to a recent report from Drugs.com, an online drug information resource. The 2 drugs, with quarterly sales in the $1.5 billion range, rank […]